TY - JOUR
T1 - Treatment pattern and outcome of spontaneous coronary artery dissection in Japan
AU - Inohara, Taku
AU - Saw, Jacqueline
AU - Kohsaka, Shun
AU - Fukuda, Keiichi
AU - Fushimi, Kiyohide
N1 - Funding Information:
Dr. Kohsaka receives grant support from Japan Society for Promotion of Science (16H05215 and 16KK0186), Bayer, Daiichi Sankyo and consultant/lecture fees from Bayer, Bristol Meier Squibb, Pfizer and AstraZeneka. Dr. Saw has received unrestricted research grant supports (from the Canadian Institutes of Health Research, Heart & Stroke Foundation of Canada, National Institutes of Health, AstraZeneca, Abbott Vascular, St Jude Medical, Boston Scientific, and Servier), salary support (Michael Smith Foundation for Health Research), speaker honoraria (AstraZeneca, Abbott Vascular, Boston Scientific, Bayer), consultancy and advisory board honoraria (AstraZeneca, Boston Scientific, Abbott Vascular, Gore and Abiomed), and proctorship honoraria (Abbott Vascular and Boston Scientific). The remaining authors have nothing to disclose.
Funding Information:
This study was funded by Grant-in-Aid for Research on Policy Planning and Evaluation from the Ministry of Health, Labour and Welfare, Japan ( H30-Seisaku-Shitei-004 ). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Background: Characteristics, treatment pattern, and outcome of spontaneous coronary artery dissection (SCAD) have not been thoroughly investigated, especially in non-Western countries. Methods: Using a nationwide administrative database in Japan, we included all women hospitalized with a diagnosis of myocardial infarction (MI) who underwent coronary angiography between 2012 and 2017. Patients with SCAD were identified using the 10th revision of the International Classification of Diseases code. Patients who underwent iatrogenic procedure-related coronary dissection were excluded. Characteristics, treatment pattern, and in-hospital mortality were compared between SCAD and non-SCAD patients. For the analysis of in-hospital mortality, age-matched and propensity score matched pairs of cohort at a ratio of 1:1 were generated. Results: Of 68,909 women patients with MI, 322 (0.5%) had SCAD. Patients with SCAD were younger (mean ± SD: 52.8 ± 13.5 years vs. 75.2 ± 11.4 years, P < 0.001) and had lower burden of comorbidity than non-SCAD patients. Percutaneous coronary intervention (PCI) was less frequently performed in SCAD patients (54.3% vs. 84.0%, P < 0.001). Among SCAD patients treated with PCI, stenting was performed in 61.7% of patients. The in-hospital mortality was significantly lower in SCAD compared with non-SCAD (2.5% vs. 7.6%, P = 0.001), which was consistent in age-matched (2.5% vs. 7.5%, P = 0.001) and propensity score matched cohorts (2.6% vs. 6.5%, P = 0.033). Conclusions: In Japan, in-hospital mortality of SCAD patients was lower than non-SCAD patients, and comparable with other international studies. However, more than half of SCAD patients were managed with PCI; further investigation is required to clarify the optimal management for this condition.
AB - Background: Characteristics, treatment pattern, and outcome of spontaneous coronary artery dissection (SCAD) have not been thoroughly investigated, especially in non-Western countries. Methods: Using a nationwide administrative database in Japan, we included all women hospitalized with a diagnosis of myocardial infarction (MI) who underwent coronary angiography between 2012 and 2017. Patients with SCAD were identified using the 10th revision of the International Classification of Diseases code. Patients who underwent iatrogenic procedure-related coronary dissection were excluded. Characteristics, treatment pattern, and in-hospital mortality were compared between SCAD and non-SCAD patients. For the analysis of in-hospital mortality, age-matched and propensity score matched pairs of cohort at a ratio of 1:1 were generated. Results: Of 68,909 women patients with MI, 322 (0.5%) had SCAD. Patients with SCAD were younger (mean ± SD: 52.8 ± 13.5 years vs. 75.2 ± 11.4 years, P < 0.001) and had lower burden of comorbidity than non-SCAD patients. Percutaneous coronary intervention (PCI) was less frequently performed in SCAD patients (54.3% vs. 84.0%, P < 0.001). Among SCAD patients treated with PCI, stenting was performed in 61.7% of patients. The in-hospital mortality was significantly lower in SCAD compared with non-SCAD (2.5% vs. 7.6%, P = 0.001), which was consistent in age-matched (2.5% vs. 7.5%, P = 0.001) and propensity score matched cohorts (2.6% vs. 6.5%, P = 0.033). Conclusions: In Japan, in-hospital mortality of SCAD patients was lower than non-SCAD patients, and comparable with other international studies. However, more than half of SCAD patients were managed with PCI; further investigation is required to clarify the optimal management for this condition.
UR - http://www.scopus.com/inward/record.url?scp=85089138720&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089138720&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2020.04.082
DO - 10.1016/j.ijcard.2020.04.082
M3 - Article
C2 - 32360646
AN - SCOPUS:85089138720
SN - 0167-5273
VL - 316
SP - 13
EP - 18
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -